Investors

Alternatives managers change tack on ESG comms

As anti-ESG rhetoric in the US intensifies, private markets players appear to be dialling down their messaging, but not their actions.

Sustainability: Managers double down on value creation and metrics

After an era of exuberance, expansion and ‘rockstar’ roles, sustainability in private markets is being more closely tethered to value creation.

Private wealth: The next frontier for private credit

A wave of evergreen fund launches aimed at opening alternative asset classes to high-net-worth individuals means many are optimistic about the viability of retail investments.

Insurers: Levelling up their game

Off the back of a slew of multibillion-dollar M&A deals, what does the future hold for the burgeoning relationship between US insurers and private credit firms?

Strategies: LPs broaden horizons

Appetite for credit secondaries, distressed and subordinated debt strategies is growing among LPs – where can the market expect to see the next wave of growth?

LPs’ view: ‘I expect ABL and credit secondaries to expand rapidly’

LPs featured in our Rising Stars 2024 list expect private credit’s fundamentals to maintain their significance over the coming months – though growth is expected in several key areas.

As Munich Re eyes new private debt assets, here’s what it wants from GPs

Private debt lead Natalia Shelestovych says the €231bn assets under management reinsurer is considering developed Asia and secondaries as investment opportunities.

Conference agrees that ABS fundamentals remain strong

Miami confab sees insurance demand, excess cash, containing spread widening.

Exclusive: Greystar holds $1.27bn close of second closed-end credit strategy

The Charleston-based manager surpassed its original $750m target for the real estate credit vehicle and has already committed $1.8bn in loans.

Private markets’ burgeoning capital concentration challenge

By appealing to retail and large institutional investors, mega-managers may end up with the lion’s share of capital, with implications for themselves and their investors, writes Cambridge Associates’ Andrea Auerbach.